Total trials

53

Active

6

Phase 3

3

Total enrollment

9,031

Read this sponsor's pipeline like an analyst.

Generate a written report: strategic focus, priority programs, pipeline shape, recent terminations and momentum, and the trials worth watching in the next 12 months.

~15-30 sec · cached for 24h

Pipeline matrix

Showing 7 of 7 active programs · click any cell for trials

InterventionEarly Phase 1Phase 1Phase 2Phase 3Phase 4N/ATotal
Stannous fluoride and Potassium nitrate Dentifrice1
Stannous fluoride Dentifrice1
Potassium nitrate Dentifrice1
Vehicle Dentifrice1
Test Dentifrice5
Colgate Cavity Protection2
Parodontax Complete Protection1

Next readouts

  • 2026-07
  • 2026-08

Top conditions

  • Dentin Sensitivity14
  • Gingivitis9
  • Pain6
  • Dental Plaque6
  • Sunscreening Agents5
  • Dentin Hypersensitivity3
  • Denture Retention3
  • Oral Hygiene2

Frequently asked questions about HALEON

How many clinical trials does HALEON have on ClinicalTrials.gov?
HALEON is listed as the lead sponsor on 53 clinical trials in ClinicalTrials.gov, 6 of which are currently active (recruiting, enrolling, or ongoing).
How many of HALEON's trials are in Phase 3?
3 of HALEON's trials are in Phase 3, spread across 7 active drug programs.
What therapeutic areas does HALEON focus on?
HALEON's most-studied conditions on ClinicalTrials.gov are Dentin Sensitivity, Gingivitis, Pain, Dental Plaque, Sunscreening Agents.
When are HALEON's next clinical trial readouts?
HALEON has 2 upcoming primary-completion readouts tracked here; the soonest is “A Clinical Study to Evaluate the Effectiveness of an Experimental Toothpaste in Improving Gum Health and Reducing Plaque Accumulation”, expected around 2026-07.